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ABSTRACT
Introduction In patients with chronic coronary 
syndrome, percutaneous coronary intervention targets 
haemodynamically significant stenoses, that is, those 
thought to cause ischaemia. Intracoronary ECG (icECG) 
detects ischaemia directly where it occurs. Thus, the goal 
of this study was to test the accuracy of icECG during 
pharmacological inotropic stress to determine functional 
coronary lesion severity in comparison to the structural 
parameter of quantitative angiographic per cent diameter 
stenosis (%S), as well as to the haemodynamic indices of 
fractional flow reserve (FFR) and instantaneous wave- free 
ratio (iFR).
Method The primary study endpoint of this prospective 
trial was the maximal change in icECG ST- segment 
shift during pharmacological inotropic stress induced 
by dobutamine plus atropine obtained within 1 min after 
reaching maximal heart rate(=220 - age). IcECG was 
acquired by attaching an alligator clamp to the angioplasty 
guidewire positioned downstream of the stenosis. For 
the pressure- derived stenosis severity ratios, coronary 
perfusion pressure and simultaneous aortic pressure were 
continuously recorded.
Results There was a direct linear relation between 
icECG ST- segment shift and %S: icECG=−0.8+0.03*%S 
(r2=0.164; p<0.0001). There were inverse linear 
correlations between FFR and %S: FFR=1.1–6.1*10–
3*%S (r2=0.494; p<0.0001), and between iFR and %S: 
iFR=1.27–8.6*10–3*%S (r2=0.461; p<0.0001). Using 
a %S- threshold of ≥50% as the reference for structural 
stenosis relevance, receiver operating characteristics- 
analysis of absolute icECG ST- segment shift during 
hyperemia showed an area under the curve (AUC) of 
0.678±0.054 (p=0.002; sensitivity=85%, specificity=50% 
at 0.34 mV). AUC for FFR was 0.854±0.037 (p<0.0001; 
sensitivity=64%, specificity=96% at 0.78), and for 
iFR it was 0.816±0.043 (p<0.0001;sensitivity=62%, 
specificity=96% at 0.83).
Conclusions Hyperaemic icECG ST- segment shift detects 
structurally relevant coronary stenotic lesions with high 
sensitivity, while they are identified highly specific by FFR 
and iFR.
INTRODUCTION
In patients with chronic coronary syndrome 
(CCS), percutaneous coronary intervention 
(PCI) targets haemodynamically relevant 
stenotic lesions, that is, those thought to cause 
ischaemia. That is, coronary lesions inducing 
flow restrictions beyond the compensatory 
autoregulation of the myocardial microcir-
culation under stress conditions. This key 
feature of coronary resistance, and thus, 
myocardial perfusion normally allows a four-
fold to fivefold blood flow increase1 (that is, 
coronary flow reserve, CFR), respectively, is 
responsible for maintaining constant resting 
myocardial perfusion of 1 mL blood per 
minute per gram over a broad range of arte-
rial perfusion pressures. Hence in patients 
with CCS, compensatory coronary vasodil-
atation preserves adequate perfusion at the 
expense of decreased CFR. Accordingly, 
in situations with higher oxygen demand, 
for example, during physical exercise, the 
limited vasodilatory reserve causes ischaemia. 
Gould and Lipscomb2 were the first to inves-
tigate these coronary pathophysiologic mech-
anisms. Based on their findings, coronary 
angiographic lesion severity of ≥50% diam-
eter narrowing has been extensively used as 
the relevant threshold for PCI.
Key questions
What is already known about this subject?
 ► Diagnostic assessment of functional stenosis rele-
vance by coronary pressure measurement (that is, 
fractional flow reserve, instantaneous wave- free 
ratio) has been shown to be efficacious on patient 
outcome.
 ► Intracoronary ECG provides a direct measure of 
myocardial ischaemia in real time, and thus, is use-
ful to predict postprocedural myocardial injury.
What does this study add?
 ► The theoretical stenosis- specificity of the pressure- 
derived functional indices was directly corroborated 
for the first time in clinical practice.
 ► Hyperaemic intracoronary ECG ST- segment shift de-
tects structurally relevant coronary stenotic lesions 
with high sensitivity
How might this impact on clinical practice?
 ► In a selected population, intracoronary ECG can act 
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Compared with the structural, mostly visual angio-
graphic approach, diagnostic assessment of functional 
stenosis relevance by coronary pressure measurement has 
been suggested to affect patient outcome.3 In comparison 
to direct measurement of coronary blood flow reserve, 
coronary pressure measurements are more robust. Given 
temporary paralysis of the coronary microcirculation, 
pressure is, theoretically, directly related to coronary 
flow.4 Thus, the pressure drop across a coronary stenosis, 
that is, fractional flow reserve (FFR5), respectively, instan-
taneous wave- free ratio (iFR6 7) provides an estimate of its 
restrictive effect on flow. However and despite their prog-
nostic value derived from large randomised clinical trials, 
both FFR and iFR rely on the, so far, untested concept 
of their being stenosis- specific,5 and not stenosis- plus 
microcirculatory- specific, the fact of which limits their 
usefulness in defining a true ischaemic threshold.
Conversely, intracoronary ECG (icECG) provides a 
direct measure of myocardial ischaemia in real time8–11 
(figure 1). Hence, the goal of this study was to test the 
amount of myocardial ischaemia by icECG during 
inotropic stress for coronary lesion severity assessment 
in comparison to structural quantitative stenosis severity 
(%S), and to established haemodynamic indices for 
lesion severity (FFR, iFR).
METHODS
Study design and patients
This was a prospective observational study in 100 patients 
with CCS undergoing diagnostic coronary angiography 
due to chest pain. The primary study endpoint was the 
maximal change in icECG ST- segment shift during phar-
macological inotropic stress induced by dobutamine plus 
atropine obtained within 1 min after reaching maximal 
heart rate in beats per minute (=220 - age). Secondary 
study endpoints were %S using biplane quantitative coro-
nary angiography, and the pressure- derived haemody-
namic indices FFR and iFR. Criteria for study inclusion 
were age >18 years, and written informed consent for 
study participation. Exclusion criteria were acute coro-
nary syndrome, severe aortic stenosis, prior myocardial 
infarction in the vascular territory undergoing study 
measurement, presence of left bundle branch block, 
presence or history of non- sinus rhythm or paced rhythm, 
contraindication to pharmacological inotropic stress as 
well as severe hepatic or renal failure (creatinine clear-
ance <15 mL/min/1.73 m2).
All patients gave written informed consent before the 
start of the study procedure.
Cardiac catheterisation and quantitative coronary 
angiography
Patients underwent left heart catheterisation and coro-
nary angiography for diagnostic purposes from the right 
radial artery approach via a 6- in- 5F introducer sheath. 
Biplane coronary angiography was performed followed 
by left ventriculography. Coronary artery stenoses were 
assessed quantitatively in two orthogonal planes as per 
cent diameter narrowing (%S) using the guiding cath-
eter for calibration. In the situation of serial coronary 
lesions, %S of the most severe stenosis was calculated.
Acquisition of the icECG
IcECG was acquired by attaching an alligator clamp to 
the 0.014- inch pressure monitoring angioplasty guide-
wire (PressureWire X Guidewire, Abbott, Chicago, Illi-
nois, USA) positioned downstream of the stenosis, and 
connecting it to a precordial lead generating a pseudo- 
unipolar lead between Wilson Central Terminal and the 
pressure sensor. Due to the structure of the pressure guide-
wire with integrated isolation, isolating the guidewire 
Figure 1 Collateral flow index measurement for the induction of reactive hyperaemia. Simultaneous recordings of mean and 
phasic aortic (upper panel, red signals), coronary occlusive pressure (upper panel, black signals) and intracoronary ECG (lower 
panel, icECG). Fractional flow reserve during reactive hyperaemia is calculated immediately after the 1 min occlusion, followed 
by angiography (marked by the outlier of the red pressure signal).
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also proximally was not required.11 IcECG recording 
was performed at a sampling frequency of 2000 Hz, and 
with standard system filtering (corresponding to a band-
passfilter 0.05–100 Hz). The primary study endpoint, 
maximal change in icECG ST- segment shift obtained 
within 1 min after reaching maximal heart rate was meas-
ured 60 ms after the J- point on 10–15 consecutive and 
signal- averaged QRS- complexes (figure 2).
Assessment of pressure-derived haemodynamic indices
For the pressure- derived ratios FFR and iFR, distal coro-
nary artery pressure (Pd, mm Hg) and aortic pressure (Pao, 
mm Hg) were continuously recorded. FFR, defined as 
‘the ratio of maximal blood flow downstream of a stenosis 
relative to unimpaired maximal blood flow (=meanPd/
meanPao) during hyperaemia’
5 was calculated continu-
ously during pharmacologic inotropic stress. In addition, 
to receive an independent reference method for the 
assessment of stenosis severity, FFR was also determined 
during reactive hyperaemia. Hyperaemia was induced by 
a 1 min proximal coronary artery balloon occlusion in 
the vessel of interest (figure 1) immediately followed by 
angiography. This method has been previously validated 
against FFRadenosine,
12 and it allowed also the determination 
of collateral flow index (CFI), defined as mean coronary 
occlusive pressure relative to mean aortic pressure, both 
subtracted by central venous pressure.13 14
IFR was calculated offline according to the proposed 
method of Sen et al6 as the pressure ratio Pd/Pao in the 
so called diastolic wave- free period. During this period, 
that is, beginning 25% of diastolic duration (ms) after 
the dicrotic notch of the phasic aortic pressure curve, 
and ending 5 ms before the start of the next ECG QRS 
complex, coronary resistance is thought to be stable and 
minimal.6
Study protocol
Immediately following right radial artery sheath inser-
tion, 5’000 units of intravenous heparin plus two puffs of 
oral isosorbidedinitrate were given. Following diagnostic 
coronary angiography, the 0.014 inch pressure moni-
toring angioplasty guidewire was set at zero, calibrated, 
advanced through the guiding catheter, and positioned 
in the distal part of the vessel downstream of the coronary 
stenosis. Special care was taken to ensure the position of 
the guidewire in the main vessel to exclude the possibility 
of coronary side branch occlusion. Before start of phar-
macologic inotropic stress, flushing of the catheter with 
15 mL of saline allowed the recording of unsmoothed 
aortic and coronary pressure signals necessary for the 
calculation of iFR. Immediately after recording of iFR, 
pharmacological inotropic stress test using intravenous 
dobutamine at a rate of 20 μg/kg/min was started for 
2 min, followed by 4 min of intravenous dobutamine at a 
rate of 40 μg/kg/min. To prevent cardiac preload reduc-
tion, that is, a conventional side effect of dobutamine, 
continuous infusion of saline was maintained throughout 
the study procedure. If the maximal heart rate (=220 
- age) was not reached after 6 min, 0.5–1 mg of intrave-
nous atropine was given. At maximal heart rate, infu-
sion of dobutamine was maintained for another minute 
to allow for full development of ischaemia. Afterwards, 
dobutamine was stopped, and esmolol (10 mg stepwise) 
was given to slow down the heart rate. During the entire 
procedure, continuous recording of the icECG, Pd and 
Pao was performed.
Figure 2 Pharmacological inotropic stress test with recording of intracoronary ECG (icECG). With increasing heart rate and 
myocardial oxygen consumption, flow impairment of the coronary lesion causes first subendocardial and later transmural 
myocardial ischaemia with a positive icECG ST- segment shift. Turquoise=IcECG of a single heartbeat, black=signal- averaged 
icECG of at least 12 consecutive QRS- complexes, %S, per cent diameter stenosis; FFR, fractional flow reserve; iFR, 
instantaneous wave- free ratio.
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After normalisation of heart rate, an adequately sized 
angioplasty balloon catheter was positioned in the ostial 
part of the vessel of interest. Coronary balloon inflation 
for measurement of CFI and induction of reactive hyper-
aemia occurred at an inflation pressure of 1–2 atmo-
spheres for exactly 1 min. Complete coronary occlusion 
was confirmed by angiography. Immediately after balloon 
deflation, reactive hyperaemia, that is, postocclusive FFR 
was obtained following angiography.
Treatment of the coronary lesion was independent of 
the study results, and at the discretion of the interven-
tional cardiologist.
Statistical analysis
For the purpose of data presentation, two study groups 
were formed based on %S (<or ≥50%). Between- group 
comparison of continuous demographic variables 
and haemodynamic parameters was performed by an 
unpaired Student’s t- test.
Linear regression analysis was performed for univar-
iate association testing between icECG ST- segment 
shift and secondary study endpoints. Non- parametric 
receiver operating characteristics (ROC) curve analysis 
was used for accuracy assessment of detecting a %S of 
≥50% defining coronary structural stenosis significance 
by icECG ST- segment shift, FFR and iFR. Comparison of 
the area under the ROC curve was performed using the 
DeLong- Test.
Statistical significance was defined at a p<0.05. Contin-
uous variables are given as mean±SD. All analyses were 
performed using SPSS V.25 (IBM Statistics) or MedCalc 
for Windows, V.19.1 (MedCalc Software, Ostend, 
Belgium).
RESULTS
One hundred patients were included in the study. Using 
the %S threshold of ≥50% as definition for structural 
significance, 52 patients were in the group with a signifi-
cant coronary stenosis.
Patient characteristics
There was no significant difference between the groups 
in terms of age, sex, body mass index or cardiovascular 
risk factors (table 1). There was a significant difference 
between the groups in Canadian cardiovascular society 
class, demonstrating a higher level of symptoms in 
patients with a significant coronary lesion. Regarding 
Table 1 Patient characteristics
Overall %S<50% %S≥50% p- value
No of patients 100 48 52 –
Patient characteristics
Age 66±11 67±10 66±11 0.623
Female gender, n (%) 25 (25) 15 (31) 10 (19) 0.176
Height (cm) 174±8 174±8 174±8 0.803
Weight (kg) 84±16 85±17 83±15 0.627
Body mass index (kg/m2) 28±5 28±5 27±4 0.523
Angina pectoris before intervention (%) 53 58 48 0.324
Duration of angina pectoris (months) 9±21 6±6 13±30 0.414
Canadian cardiovascular society class of angina pectoris 2.10±1.05 1.67±0.83 2.56±1.12 0.002
Diabetes mellitus (%) 23 21 25 0.643
Arterial hypertension (%) 69 67 71 0.670
Current smoking (%) 12 8 15 0.362
Cumulative pack years of cigarettes 38±21 36±20 40±24 0.664
Dyslipidaemia (%) 73 75 71 0.822
Family history for coronary artery disease (%) 32 33 31 0.832
Prior myocardial infarction (%) 37 29 44 0.148
Medical treatment
Aspirin (%) 87 83 90 0.377
Platelet inhibitor (%) 43 38 48 0.317
Calcium channel- blocker (%) 27 31 23 0.377
Beta- blocker (%) 51 42 60 0.109
Nitrate (%) 12 15 10 0.544
Oral anticoagulation (%) 7 6 8 1.000
Statin (%) 77 77 77 1.000
ACE- inhibitor or ARB (%) 71 63 79 0.082
Diuretics (%) 28 33 23 0.274
ACE, angiotensin- converting enzyme; ARB, angiotensin receptor blocker.
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cardiovascular medication, there was no difference 
between the groups.
Haemodynamic and coronary angiography data
There was no significant difference between the groups 
in basic haemodynamic parameters, that is, heart rate at 
rest, left ventricular ejection fraction or arterial blood 
pressure. Patients with a %S ≥50% showed a higher 
number of structurally relevant stenoses on coronary 
angiogram (table 2).
Left anterior descending artery served more often as 
the study vessel than other coronary arteries; maximum 
heart rate was similar between the groups. Overall, %S, 
FFR and iFR were equal to 53±17, 0.789±0.143, and 
0.812±0.209, respectively.
There was a direct linear relation between icECG 
ST- segment shift and %S: icECG = -0.8+0.03*%S 
(r2=0.164; p<0.001, figure 3). There were inverse linear 
correlations between FFR and %S: FFR=1.1–6.1*10-3*%S 
(r2=0.494; p<0.001, figure 4), and between iFR and %S: 
iFR=1.27–8.6*10-3*%S (r2=0.461; p<0.001, figure 4).
Using a %S threshold of ≥50% as the reference for 
structural stenosis relevance, ROC- analysis of absolute 
icECG ST- segment shift showed an area under the curve 
(AUC) of 0.678±0.054 (p=0.002). AUC for FFR was 
0.854±0.037 (p<0.0001), and for iFR it was 0.816±0.043 
(p<0.0001, figure 5).
The DeLong- Test of the ROC- curves showed a signifi-
cant difference for FFR and iFR as compared with icECG 
ST- segment shift (p=0.002, respectively p=0.024). There 
was no relevant difference in AUC between FFR and iFR 
(p=0.3151).
Regarding the optimum cut- off for icECG, an abso-
lute ST- segment shift of 0.34 mV (taken 60 ms after the 
J- point) distinguished best between haemodynamically 
relevant and irrelevant stenotic lesions; sensitivity 85%, 
specificity 50%.
The best cut- off point for FFR to detect a %S≥50% was 
0.78 (sensitivity 64%, specificity 96%). For iFR, the best 
cut- off point was 0.83 (sensitivity 62%, specificity 96%).
Table 2 Haemodynamic parameters
Overall %S<50% %S≥50% p- value
Heart rate (beats per minute) 77±16 76±20 78±12 0.545
Systolic blood pressure (mm Hg) 122±21 121±20 124±22 0.540
Diastolic blood pressure (mm Hg) 66±12 66±11 67±12 0.578
Left ventricular end- diastolic pressure (mm Hg) 11±6 11±6 11±6 0.898
Left ventricular ejection fraction (%) 63±8 64±7 63±8 0.552
Coronary angiographic parameters
No of diseased vessels 1.81±0.94 1.50±0.99 2.10±0.84 0.001
No of coronary lesions (visually relevant) 1.83±1.60 1.21±1.21 2.38±1.68 <0.001
Target vessel distribution
Left anterior descending, n 55 23 32 0.362
Left circumflex coronary artery, n 24 14 10
Right coronary artery, n 21 11 10
Study parameters
Maximum heart rate achieved (beats per minute) 150±16 149±18 151±13 0.508
Maximal heart rate in % of theoretical maximal heart rate (220- age) 98±11 98±12 98±10 0.705
Quantitative coronary angiography of the lesion of interest (%) 53±17 39±6 66±12 –
Fractional flow reserve 0.798±0.143 0.887±0.073 0.716±0.143 <0.001
Instantaneous wave- free ratio 0.812±0.209 0.922±0.052 0.710±0.245 <0.001
Intracoronary ECG ST- segment shift measured @ J- Point +60 ms (mV) 
within 1 min after maximal heart rate
0.965±1.324 0.545±0.892 1.352±1.533 0.002
Collateral flow index 0.118±0.100 0.083±0.070 0.148±0.113 0.001
Figure 3 Linear regression between intracoronary ECG 
(icECG) ST- segment shift and per cent diameter coronary 
stenosis. solid line=regression line; dashed line=marker for 
0 mV icECG ST- segment shift.
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Adverse events associated with dobutamine/atropine 
infusion were the following: one ventricular fibrillation 
requiring defibrillation (provoked by wedge position of 
the guiding catheter during maximal hyperemia), and 
two cases of supraventricular tachycardia (terminated 
during esmolol infusion at the end of the study protocol).
DISCUSSION
When tested against the structural parameter of per cent 
diameter coronary narrowing, haemodynamically rele-
vant stenotic lesions are -overall- detected less accurately 
by icECG ST- segment shift during myocardial ischaemia 
than by hyperaemic FFR or diastolic wave- free coro-
nary pressure ratio. The theoretically claimed stenosis- 
specificity of the pressure- derived functional indices 
was directly corroborated for the first time in our study, 
while icECG during hyperaemia very sensitively detected 
a relevant coronary stenosis responsible for myocardial 
ischaemia.
icECG as direct indicator of myocardial physiology
The ECG is essential in the diagnosis of myocardial 
ischaemia, the amount of which is a crucial prognostic 
factor.15 The commonly used surface ECG is, however, 
limited in detecting short- lasting or minor myocardial 
ischaemia. Conversely, due to its close vicinity to the 
myocardium, icECG is much more sensitive than surface 
ECG in detecting myocardial ischaemia.8 Thus, several 
clinical trials have assessed the value of icECG to guide 
PCI, and rated it useful to predict postprocedural myocar-
dial injury.9 16
The detection of vasodilator- induced ischaemia by 
icECG is not unprecedented. Balian et al11 compared 
icECG ST- segment shift during intravenous adenosine 
with FFR. Eighty- one per cent of the 48 patients with an 
FFR ≤0.80 showed a significant icECG ST- segment shift 
during adenosine infusion, while 14% did so despite an 
FFR >0.80 (false positive cases). The major limitation of 
the study as stated by the authors was the induction of 
coronary perfusion heterogeneity by adenosine, that is, 
coronary steal.11 Hence, the use of dobutamine as a phar-
macologic simulator of physical exercise with consec-
utive physiological hyperaemia might be preferable, 
since unmasking a haemodynamically relevant coronary 
stenosis does not require asymmetric stenosis distribu-
tion within the coronary tree as in the case of adenosine- 
induced hyperaemia.
Using dobutamine/atropine for ischaemia induc-
tion, icECG ST- segment shift showed a significant, but 
modest linear correlation with per cent diameter stenosis 
(r2=0.164, figure 3). However, myocardial ischaemia, that 
is, the cause of icECG ST- segment shift, does not only 
Figure 4 Linear regression between fractional flow reserve, respectively, instantaneous wave- free ratio and per cent diameter 
coronary stenosis. Solid lines=regression lines; dashed lines=common thresholds, that is, %S≥50%, FFR ≤0.80, iFR ≤0.89. %S, 
per cent diameter stenosis; FFR, fractional flow reserve; iFR, instantaneous wave- free ratio.
Figure 5 Non- parametric receiver- operating characteristic 
curve of intracoronary ECG (icECG) ST- segment shift, 
FFR and iFR, using a %S threshold of 50% as structural 
significance definition. The black circle marks the best cut- off 
point for icECG ST- segment shift according to the Youden- 
Index: 0.34 mV, sensitivity 85%, specificity 50%. %S, per 
cent diameter stenosis; FFR, fractional flow reserve; iFR, 
instantaneous wave- free ratio.
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depend on structural stenosis severity, but also on the area 
of ischaemic myocardium, and on the extent of coronary 
collateral blood supply. Accounting for these different 
determinants of ischaemia, the accuracy analysis results 
for icECG ST- segment shift is not surprising, showing a 
high sensitivity but a low specificity for structural stenosis 
relevance (figure 5). Hence, icECG could act as a rule out 
diagnostic test, that is, a functional test with high nega-
tive predictive value similar to the non- invasive coronary 
computed tomography angiography. Practically speaking, 
the presence of myocardial ischaemia on icECG with a 
ST- segment shift of >0.34 mV requires further structural 
and/or function assessment while the absence of isch-
aemia allows abstaining from further tests.
Aside from its high test sensitivity for detecting structur-
ally relevant stenoses, icECG has a remarkable temporal 
sensitivity for dynamically changing ischaemia as illus-
trated by figure 2. IcECG as the vectored sum of energy 
dependant electrical processes in myocardial cells directly 
reflects the adequacy of myocardial perfusion, and is able 
to detect subtle voltage changes. Thus, in this patient 
with a haemodynamically significant coronary lesion 
(FFR=0.66, iFR=0.76, %S=68%), icECG recorded shortly 
after the start of the pharmacologic stress test showed 
subendocardial ischaemia. With progressive pharmaco-
logical stress, regional ischaemia extended across the 
myocardial wall. Transmural ischaemia, however, resolved 
quickly after termination of dobutamine infusion.
Taken together, for the detection of coronary struc-
tural (figure 5) as well as myocardial temporal supply 
(figure 2) changes, icECG is a highly sensitive instrument.
Assessment of haemodynamic significance of epicardial 
coronary lesions
Gould et al showed that epicardial coronary lesions cause 
diminished flow at rest once the arterial diameter reduc-
tion reaches 80%, or 50% in case of maximal coronary 
blood flow.17 Thus, quantitative coronary angiography 
has offered a well- documented basis for revascularisation 
given a non- diseased reference diameter as obtained in 
more than one image projection. Yet, physician- based 
visual assessment with its notorious tendency to over-
estimate lesion severity remained the standard method 
instead of quantitative angiographic assessment for 
guiding revascularisation.18
Hence, to reduce unnecessary PCIs of coronary 
lesions, haemodynamic stenosis parameters have been 
introduced. FFR, which first has been validated against 
exercise stress testing to determine a cut- off value for 
inducible myocardial ischaemia (FFR ≤0.6619) has later 
been compared with various exercise stress tests, dobu-
tamine stress echocardiography and myocardial perfu-
sion imaging yielding a threshold for stenosis relevance 
of 0.75.5 In the subsequent FFR versus Angiography for 
Multivessel Evaluation (FAME- trials), a higher cut- off 
value of 0.80 has been selected based on the previously 
demonstrated practice of interventional cardiologists 
to perform PCI in the grey zone of 0.75–0.80.20 Among 
patients preselected for PCI by conventional visual 
(instead of quantitative) coronary angiographic assess-
ment, the FAME-1 trial documented an advantage of 
angiography- plus FFR- guided versus angiography- guided 
PCI on major adverse cardiac events after 1 year.21
In theory, FFR has been thought to be stenosis- specific 
under the -uncertain- condition of adenosine- induced 
constant and minimal coronary arterial microcirculatory 
resistance.22 This concept has been mutually adopted 
based on an early study claiming FFR to be ‘a lesion- 
specific index that reflects the effect of the epicardial 
stenosis on maximum myocardial perfusion’.22 In this 
regard, the present study’s results corroborated for the 
first time the assumption of FFR’s stenosis specificity, 
revealing specificity values of 96% for both FFR and 
iFR when tested against the truly structural quantitative 
parameter of %S (figure 5). Of note, the optimum cut- 
off value for FFR to detect a structural relevant stenosis of 
≥50% diameter narrowing was 0.78, thus demonstrating 
an almost perfect agreement with the commonly used 
FFR threshold of 0.80.
More recently, a drug- free and thus more practical 
approach for haemodynamic stenosis assessment, iFR, 
has been introduced and compared with FFR, yielding 
good agreement between the two indices.6 In a subse-
quent clinical trial using a threshold of ≤0.89, iFR has 
been proven non- inferior to FFR in guiding PCI.7 In 
regard to our study results, iFR showed an almost iden-
tical diagnostic performance to FFR with the same speci-
ficity, that is, demonstrating stenosis- specificity as well.
Nevertheless, both indices are affected by the distri-
bution of coronary atherosclerotic disease, by asymmet-
rically distributed regional vascular resistances. This can 
only be accounted for by direct regional assessment of 
myocardial ischaemia as with icECG. In a broader sense 
and in the context of coronary blood flow as the source 
for the myocardium,4 icECG reflects the adequacy of 
regional myocardial perfusion.
ECG and haemodynamic mismatch
It is important to reiterate, that coronary pressure indices 
are not a true reference for myocardial ischaemia. Accord-
ingly, a value below the threshold does not automatically 
represent myocardial ischaemia, but rather indicates 
a higher probability to induce myocardial ischaemia. 
Consequently, lesions with lower vs higher values benefit 
more from revascularisation as shown previously.23 The 
oversimplification of the relation between a coronary 
pressure ratio and myocardial ischaemia has been further 
demonstrated by the comparison of FFR and CFR, 
showing disagreement between the two methods in 40% 
of cases.24 There, the discrepancy has been assumed to be 
the result of variable stenosis morphology and its effect 
on coronary blood flow, that is, that focal atherosclerotic 
disease can cause a relevant pressure drop without rele-
vant impairment of coronary blood flow.24
A similar situation was also encountered in the present 
study using the icECG as indicator for myocardial 
P
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ischaemia. Applying a binary cut- off of 0.6 mV for icECG, 
as derived from the surface ECG cut- off of 0.1 mV and 
adjusted to the sixfold higher signal amplitude of the 
icECG, and an iFR cut- off of 0.89, only 29% of the cases 
were concordant in demonstrating absent ischaemia, and 
31% were concordant with ischaemia; 17% were discor-
dant without ischaemia in the presence of focal disease, 
while 23% were discordant in the presence of diffuse or 
small- vessel disease. IcECG in combination with coronary 
pressure- derived indices allow comprehensive assess-
ment of myocardial perfusion and thus, also an appraisal 
of the regional extent of atherosclerotic disease. Taken 
into account the results of the FAME- II- trial, where 80% 
of patients with abnormal FFR values did not experience 
cardiac events throughout the 2- year follow- up period,4 25 
an optimal functional assessment should be preferred.
Study limitations
The major limitation of this study is the lack of infor-
mation on cardiovascular outcome as a function of 
the amount of myocardial ischaemia by icECG ST- seg-
ment shift. Although myocardial ischaemia was proven 
several times as the principal predictor of cardiovascular 
outcome,15 its assessment would have increased the 
validity of the presented method. However, the present 
study was primarily designed to evaluate the interaction 
between structural and functional parameters of myocar-
dial ischaemia. Thus, it would have been underpowered 
as an outcome trial.
Additionally, the employed stress test required an elab-
orated study protocol, which prolonged the assessment 
of coronary lesion severity. However, the observed high 
test sensitivity of icECG can be attributed to dobutamine/
atropine for ischaemia induction. In a post hoc analysis 
with assessment of the icECG ST- segment shift during 
reactive hyperaemia (that is, simultaneous assessment 
with the FFR), diagnostic performance shifted towards a 
higher specificity while completely losing sensitivity.
Clinical implication
IcECG is an easy to acquire parameter providing insight 
into myocardial physiology in real time with a fraction of 
the costs as it does not require expensive pressure moni-
toring angioplasty guidewires. Clinical application is, 
however, for a selected population with relative contrain-
dications to PCI (for example bleeding history), where 
the prolonged measurement duration is out- weighed 
by the importance of accurate coronary lesion assess-
ment. There, icECG can act as a high- sensitivity rule out 
test for relevant stenosis severity. Consequently, absence 
of ischaemia in the icECG during pharmacological 
inotropic stress represents maintained coronary blood 
flow and thus, PCI can be deferred. On the other hand, 
icECG ST- segment shift in combination with normal iFR 
may reflect diffuse epicardial or microvascular disease 
with a hampered vasodilator reserve capacity, in which 
case medical treatment would be indicated.26
CONCLUSION
Hyperaemic icECG ST- segment shift detects structurally 
relevant coronary stenotic lesions with high sensitivity, 
while they are identified highly specific by FFR and iFR.
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